Recent 8-K filings for JYNT

• May 07, 2026 23:59 UTC earnings materiality 0.75 neutral item 1.01item 2.03item 2.02item 7.01item 9.01

  JYNT Q1 revenue up 13%, net income up 34%; credit covenant default waived

  Revenue $14.8M (+13% YoY); net income from continuing ops $1.1M vs loss $506K prior year.

• May 01, 2026 23:59 UTC other_material materiality 0.85 positive item 8.01item 9.01

  The Joint Corp. sells 45 Southern California clinics for $2.3M, moves to pure franchisor model

  45 clinics sold to Elite Chiro Group for $2.3M; 13 closed on April 27, 2026.

• Apr 24, 2026 23:59 UTC m_and_a materiality 0.70 neutral item 1.01item 9.01

  Joint Corp. agrees to sell 45 Southern California clinics to Elite Chiro Group for $2.3M

  Total purchase price $2.3M, includes $150k non-refundable down payment; remainder paid into escrow.

• Mar 12, 2026 23:59 UTC earnings materiality 0.75 neutral item 2.02item 7.01item 9.01

  Joint Corp Q4 revenue $15.2M (+3.1% YoY); FY2025 net income $2.9M; guides FY2026 system-wide sales $519-552M

  Q4 revenue $15.2M (+3.1% YoY); net income from continuing ops $937K vs $909K.

• Jan 12, 2026 23:59 UTC other_material materiality 0.60 neutral item 1.01item 9.01

  Joint Corp. agrees to nominate activist investor Jefferson Gramm to board

  Letter agreement with Bandera Partners LLC requires company to include Jefferson Gramm in director slate for 2026 annual meeting.

• Jan 09, 2026 23:59 UTC other_material materiality 0.65 neutral item 1.01item 9.01

  Joint Corp. agrees to nominate activist investor Jefferson Gramm to board at 2026 annual meeting

  Company will nominate Jefferson Gramm (Bandera Partners) and recommend his election at 2026 annual meeting.

• Dec 11, 2025 23:59 UTC m_and_a materiality 0.70 neutral item 1.01item 1.02item 9.01

  Joint Corp signs $1.5M APA for 22 SE clinics, terminates $4.5M APA for 45 CA clinics

  Sold 22 clinics in VA, NC, SC for aggregate purchase price of $1,482,800; buyers are existing franchisees/operators.

• Nov 06, 2025 23:59 UTC earnings materiality 0.75 positive item 1.01item 2.02item 7.01item 8.01item 9.01

  Joint Corp Q3 net income turns positive to $855K; sells 45 clinics for $4.5M; adds $12M buyback

  Q3 revenue $13.4M (+6% YoY); consolidated net income $855K vs loss of $3.2M in Q3 2024.

• Oct 06, 2025 23:59 UTC other_material materiality 0.70 neutral item 1.01item 2.03item 9.01

  The Joint Corp. to refranchise all company clinics; credit maturity extended to Aug 2027

  Consent to refranchise 100% of company-owned/managed clinics to franchisees by Dec 31, 2025.

• Aug 27, 2025 23:59 UTC leadership materiality 0.55 neutral item 1.01item 5.02item 9.01

  Former CFO Jake Singleton to receive $171,959 severance, accrued PTO, and $15K under separation agreement

  CFO Jake Singleton's employment ended June 9, 2025; separation agreement signed Aug 22, 2025, includes general release of claims.

• Aug 07, 2025 23:59 UTC earnings materiality 0.80 negative item 2.02item 7.01item 9.01

  Joint Corp Q2 rev $13.3M +5%, narrows loss; cuts FY system-wide sales guidance to $530-550M

  Q2 revenue $13.3M (+5% YoY); consolidated net income $93K vs loss $3.6M; net loss from continuing ops $990K vs loss $1.7M.

• Jul 30, 2025 23:59 UTC other_material materiality 0.70 negative item 2.02item 4.02item 9.01

  The Joint Corp. to restate FY2024 and Q1 2025 results due to overestimated impairment charges by ~$2.2M

  Expects to reduce 2024 net loss by ~$2.2M and increase carrying value of assets held for sale by ~$2.2M.

• Jul 07, 2025 23:59 UTC m_and_a materiality 0.75 positive item 2.01item 9.01

  The Joint Corp. closes sale of 31 clinics for $11.13M, acquires NW region RD rights

  Sold 31 company-owned clinics in AZ/NM to Joint Ventures, LLC for $11.13M (includes $8.3M cash).

• Jun 27, 2025 23:59 UTC m_and_a materiality 0.80 positive item 1.01item 8.01item 9.01

  The Joint sells 31 clinics for $11.07M, acquires NW region rights, refranchises 5 clinics

  Sale of 31 corporate clinics to Joint Ventures, LLC for $11.07M; buyer to own 96 clinics total.

• Jun 10, 2025 23:59 UTC leadership materiality 0.55 neutral item 1.01item 5.02item 7.01item 9.01

  The Joint Corp. names Scott J. Bowman CFO, replacing Jake Singleton

  Scott J. Bowman appointed CFO effective June 10, 2025; Jake Singleton separated June 9, 2025.

• Jun 05, 2025 23:59 UTC other_material materiality 0.55 positive item 5.02item 7.01item 8.01item 9.01

  The Joint Corp. adds director Sandi Karrmann and authorizes $5M stock buyback

  Appointed Sandra R.A. Karrmann as director; board increases to eight; she will chair Compensation Committee.

• May 22, 2025 23:59 UTC other materiality 0.10 neutral item 5.07item 9.01

  Joint Corp. shareholders elect all seven director nominees, approve say-on-pay, ratify auditor at annual meeting

  All seven Board nominees elected, including Matthew Rubel, Ronald DaVella, and Sanjiv Razdan.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.85 · Median 0.70 · Most common event other_material

5 positive 2 negative 10 neutral

source · JYNT on sec.gov